Predicting transfusion in shoulder arthroplasty

Ross A. Schumer, Jonathan S. Chae, Ronald J. Markert, Dominic Sprott, Lynn A Crosby

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: This study was conducted to evaluate the incidence of transfusion in shoulder arthroplasty, determine clinical factors associated with increased risk for transfusion, and develop an algorithm to assist the surgeon in preoperative planning with regards to blood management. Material and methods: The study had 2 phases: (1) development of a clinical prediction rule for transfusion using 280 procedures and (2) a validation study of the algorithm applied to 109 new patients. Phase 1 consisted of a retrospective record review of 280 consecutive shoulder arthroplasties to determine risk factors for transfusion. Phase 1 also identified a preoperative hemoglobin level of less than 12.5 g/dL as predictive of the need for blood transfusion. This cutoff was prospectively applied to 109 patients undergoing shoulder arthroplasty in phase 2. Results: The transfusion rate for phase 1 was 19.6%. Preoperative hemoglobin level (P < .001), age (P= .003), and the number of comorbid conditions (P = .005) were statistically significant risk factors. Patients with a preoperative hemoglobin level of less than 12.5 g/dL have a 4-fold increased risk of requiring a blood transfusion. In phase 2, the cutoff of less than 12.5 g/dL yielded a sensitivity of 88%, specificity of 78%, and positive and negative likelihood ratios of 4.0 and 0.15, respectively. Conclusion: Preoperative hemoglobin level, age, and number of comorbid conditions are all predictive of transfusion in shoulder arthroplasty. Tailoring blood ordering based on a preoperative hemoglobin level of 12.5 g/dL is safe and effective. Level of evidence: Prognostic study, level 2.

Original languageEnglish (US)
Pages (from-to)91-96
Number of pages6
JournalJournal of Shoulder and Elbow Surgery
Volume19
Issue number1
DOIs
StatePublished - Jan 1 2010

Fingerprint

Arthroplasty
Hemoglobins
Blood Transfusion
Decision Support Techniques
Validation Studies
Sensitivity and Specificity
Incidence

Keywords

  • Shoulder arthroplasty
  • comorbidities
  • prediction
  • risk factors
  • transfusion

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Schumer, R. A., Chae, J. S., Markert, R. J., Sprott, D., & Crosby, L. A. (2010). Predicting transfusion in shoulder arthroplasty. Journal of Shoulder and Elbow Surgery, 19(1), 91-96. https://doi.org/10.1016/j.jse.2009.05.001

Predicting transfusion in shoulder arthroplasty. / Schumer, Ross A.; Chae, Jonathan S.; Markert, Ronald J.; Sprott, Dominic; Crosby, Lynn A.

In: Journal of Shoulder and Elbow Surgery, Vol. 19, No. 1, 01.01.2010, p. 91-96.

Research output: Contribution to journalArticle

Schumer, RA, Chae, JS, Markert, RJ, Sprott, D & Crosby, LA 2010, 'Predicting transfusion in shoulder arthroplasty', Journal of Shoulder and Elbow Surgery, vol. 19, no. 1, pp. 91-96. https://doi.org/10.1016/j.jse.2009.05.001
Schumer, Ross A. ; Chae, Jonathan S. ; Markert, Ronald J. ; Sprott, Dominic ; Crosby, Lynn A. / Predicting transfusion in shoulder arthroplasty. In: Journal of Shoulder and Elbow Surgery. 2010 ; Vol. 19, No. 1. pp. 91-96.
@article{94125bca35924523b8ea4008a894e0c5,
title = "Predicting transfusion in shoulder arthroplasty",
abstract = "Background: This study was conducted to evaluate the incidence of transfusion in shoulder arthroplasty, determine clinical factors associated with increased risk for transfusion, and develop an algorithm to assist the surgeon in preoperative planning with regards to blood management. Material and methods: The study had 2 phases: (1) development of a clinical prediction rule for transfusion using 280 procedures and (2) a validation study of the algorithm applied to 109 new patients. Phase 1 consisted of a retrospective record review of 280 consecutive shoulder arthroplasties to determine risk factors for transfusion. Phase 1 also identified a preoperative hemoglobin level of less than 12.5 g/dL as predictive of the need for blood transfusion. This cutoff was prospectively applied to 109 patients undergoing shoulder arthroplasty in phase 2. Results: The transfusion rate for phase 1 was 19.6{\%}. Preoperative hemoglobin level (P < .001), age (P= .003), and the number of comorbid conditions (P = .005) were statistically significant risk factors. Patients with a preoperative hemoglobin level of less than 12.5 g/dL have a 4-fold increased risk of requiring a blood transfusion. In phase 2, the cutoff of less than 12.5 g/dL yielded a sensitivity of 88{\%}, specificity of 78{\%}, and positive and negative likelihood ratios of 4.0 and 0.15, respectively. Conclusion: Preoperative hemoglobin level, age, and number of comorbid conditions are all predictive of transfusion in shoulder arthroplasty. Tailoring blood ordering based on a preoperative hemoglobin level of 12.5 g/dL is safe and effective. Level of evidence: Prognostic study, level 2.",
keywords = "Shoulder arthroplasty, comorbidities, prediction, risk factors, transfusion",
author = "Schumer, {Ross A.} and Chae, {Jonathan S.} and Markert, {Ronald J.} and Dominic Sprott and Crosby, {Lynn A}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.jse.2009.05.001",
language = "English (US)",
volume = "19",
pages = "91--96",
journal = "Journal of Shoulder and Elbow Surgery",
issn = "1058-2746",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Predicting transfusion in shoulder arthroplasty

AU - Schumer, Ross A.

AU - Chae, Jonathan S.

AU - Markert, Ronald J.

AU - Sprott, Dominic

AU - Crosby, Lynn A

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background: This study was conducted to evaluate the incidence of transfusion in shoulder arthroplasty, determine clinical factors associated with increased risk for transfusion, and develop an algorithm to assist the surgeon in preoperative planning with regards to blood management. Material and methods: The study had 2 phases: (1) development of a clinical prediction rule for transfusion using 280 procedures and (2) a validation study of the algorithm applied to 109 new patients. Phase 1 consisted of a retrospective record review of 280 consecutive shoulder arthroplasties to determine risk factors for transfusion. Phase 1 also identified a preoperative hemoglobin level of less than 12.5 g/dL as predictive of the need for blood transfusion. This cutoff was prospectively applied to 109 patients undergoing shoulder arthroplasty in phase 2. Results: The transfusion rate for phase 1 was 19.6%. Preoperative hemoglobin level (P < .001), age (P= .003), and the number of comorbid conditions (P = .005) were statistically significant risk factors. Patients with a preoperative hemoglobin level of less than 12.5 g/dL have a 4-fold increased risk of requiring a blood transfusion. In phase 2, the cutoff of less than 12.5 g/dL yielded a sensitivity of 88%, specificity of 78%, and positive and negative likelihood ratios of 4.0 and 0.15, respectively. Conclusion: Preoperative hemoglobin level, age, and number of comorbid conditions are all predictive of transfusion in shoulder arthroplasty. Tailoring blood ordering based on a preoperative hemoglobin level of 12.5 g/dL is safe and effective. Level of evidence: Prognostic study, level 2.

AB - Background: This study was conducted to evaluate the incidence of transfusion in shoulder arthroplasty, determine clinical factors associated with increased risk for transfusion, and develop an algorithm to assist the surgeon in preoperative planning with regards to blood management. Material and methods: The study had 2 phases: (1) development of a clinical prediction rule for transfusion using 280 procedures and (2) a validation study of the algorithm applied to 109 new patients. Phase 1 consisted of a retrospective record review of 280 consecutive shoulder arthroplasties to determine risk factors for transfusion. Phase 1 also identified a preoperative hemoglobin level of less than 12.5 g/dL as predictive of the need for blood transfusion. This cutoff was prospectively applied to 109 patients undergoing shoulder arthroplasty in phase 2. Results: The transfusion rate for phase 1 was 19.6%. Preoperative hemoglobin level (P < .001), age (P= .003), and the number of comorbid conditions (P = .005) were statistically significant risk factors. Patients with a preoperative hemoglobin level of less than 12.5 g/dL have a 4-fold increased risk of requiring a blood transfusion. In phase 2, the cutoff of less than 12.5 g/dL yielded a sensitivity of 88%, specificity of 78%, and positive and negative likelihood ratios of 4.0 and 0.15, respectively. Conclusion: Preoperative hemoglobin level, age, and number of comorbid conditions are all predictive of transfusion in shoulder arthroplasty. Tailoring blood ordering based on a preoperative hemoglobin level of 12.5 g/dL is safe and effective. Level of evidence: Prognostic study, level 2.

KW - Shoulder arthroplasty

KW - comorbidities

KW - prediction

KW - risk factors

KW - transfusion

UR - http://www.scopus.com/inward/record.url?scp=71649093591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71649093591&partnerID=8YFLogxK

U2 - 10.1016/j.jse.2009.05.001

DO - 10.1016/j.jse.2009.05.001

M3 - Article

VL - 19

SP - 91

EP - 96

JO - Journal of Shoulder and Elbow Surgery

JF - Journal of Shoulder and Elbow Surgery

SN - 1058-2746

IS - 1

ER -